申请人:Stichting Rega VZW
公开号:US05607922A1
公开(公告)日:1997-03-04
1,5-Anhydrohexitol nucleoside analogues represented by the general formula I: ##STR1## wherein the hexitol has the D-configuration and the carbon atom on which the base moiety and the X substituent stand both have the (S)-configuration and further wherein: B is a heterocyclic ring selected from the group consisting of pyrimidine and purine bases; and X is hydrogen, azido, F, Cl, Br, I, amino, --NHR.sup.2, --N(R.sup.2).sub.2, --OR.sup.2, --SR.sup.2, or CN; wherein R.sup.1 and R.sup.2 are the same or different and are selected from the group consisting of hydrogen, substituted or unsubstituted C.sub.1 -C.sub.20 alkyl, substituted or unsubstituted C.sub.1 -C.sub.20 alkenyl, aroyl, C.sub.1 -C.sub.20 alkanoyl, and phosphoryl. These nucleoside analogues are useful as antiviral agents against herpes simplex virus, vaccina virus, or varicella zoster virus. The definition of the X group should include --N(R.sup.2).sub.2 instead of --N(N.sup.2).sub.2.
1,5-去水己醇核苷类似物的一般式I为:##STR1## 其中,己醇具有D-构型,基团和X取代基所在的碳原子均具有(S)-构型,进一步地:B是从嘧啶和嘌呤碱基组成的杂环;X为氢、叠氮基、氟、氯、溴、碘、氨基、--NHR.sup.2、--N(R.sup.2).sub.2、--OR.sup.2、--SR.sup.2或CN,其中R.sup.1和R.sup.2相同或不同,选自氢、取代或未取代的C.sub.1-C.sub.20烷基、取代或未取代的C.sub.1-C.sub.20烯基、芳酰基、C.sub.1-C.sub.20酰基和磷酰基。这些核苷类似物可用作抗病毒剂,用于对抗单纯疱疹病毒、牛痘病毒或水痘带状疱疹病毒。X基团的定义应包括--N(R.sup.2).sub.2而非--N(N.sup.2).sub.2。